The Role of Metallothionein in Oxidative Stress

Halliwell, 1986, Oxygen free-radicals and iron in relation to biology and medicine—Some problems and concepts, Arch. Biochem. Biophys, 246, 501, 10.1016/0003-9861(86)90305-X

Cadenas, 1989, Biochemistry of oxygen-toxicity, Annu. Rev. Biochem, 58, 79, 10.1146/annurev.bi.58.070189.000455

Valko, 2004, Role of oxygen radicals in DNA damage and cancer incidence, Mol. Cell. Biochem, 266, 37, 10.1023/B:MCBI.0000049134.69131.89

Poli, 2004, Oxidative stress and cell signalling, Curr. Med. Chem, 11, 1163, 10.2174/0929867043365323

Halliwell, 1996, Antioxidants in human health and disease, Annu. Rev. Nutr, 16, 33, 10.1146/annurev.nu.16.070196.000341

Gutteridge, 1992, Comments on review of free-radicals in biology and medicine, Free Radic. Biol. Med, 12, 93, 10.1016/0891-5849(92)90062-L

Niki, 2010, Free radicals in biology and medicine: Good, unexpected, and uninvited friends, Free Radic. Biol. Med, 49, S2, 10.1016/j.freeradbiomed.2010.10.666

Halliwell, B., and Gutteridge, J.M.C. (1985). Free-Radicals in Biology and Medicine, Clarendon Press.

Pacher, 2007, Nitric oxide and peroxynitrite in health and disease, Physiol. Rev, 87, 315, 10.1152/physrev.00029.2006

Ramalingam, 2012, Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases, J. Neural Transm, 119, 891, 10.1007/s00702-011-0758-7

Pourova, 2010, Reactive oxygen and nitrogen species in normal physiological processes, Acta Physiol, 198, 15, 10.1111/j.1748-1716.2009.02039.x

Vasak, 2005, Advances in metallothionein structure and functions, J. Trace Elements Med Biol, 19, 13, 10.1016/j.jtemb.2005.03.003

Henkel, 2004, Metallothioneins: Zinc, cadmium, mercury, and copper thiolates and selenolates mimicking protein active site features—Structural aspects and biological implications, Chem. Rev, 104, 801, 10.1021/cr020620d

Coyle, 2002, Metallothionein: The multipurpose protein, Cell. Mol. Life Sci, 59, 627, 10.1007/s00018-002-8454-2

Margoshes, 1957, A cadmium protein from equine kidney cortex, J. Am. Chem. Soc, 79, 4813, 10.1021/ja01574a064

Kagi, 1988, Biochemistry of metallothionein, Biochemistry, 27, 8509, 10.1021/bi00423a001

Vasak, 2002, Advances in the structure and chemistry of metallothioneins, J. Inorg. Biochem, 88, 388, 10.1016/S0162-0134(01)00347-6

Davis, 2000, Metallothionein expression in animals: A physiological perspective on function, J. Nutr, 130, 1085, 10.1093/jn/130.5.1085

Klaassen, 2009, Metallothionein protection of cadmium toxicity, Toxicol. Appl. Pharmacol, 238, 215, 10.1016/j.taap.2009.03.026

Templeton, 1991, Toxicological significance of metallothionein, Methods Enzymol, 205, 11, 10.1016/0076-6879(91)05079-B

Kagi, 1991, Overview of metallothionein, Methods Enzymol, 205, 613, 10.1016/0076-6879(91)05145-L

Shaw, 1991, Ligand substitution and sulfhydryl reactivity of metallothionein, Methods Enzymol, 205, 401, 10.1016/0076-6879(91)05122-C

Karin, 1983, Expression and regulation of a human metallothionein gene carried on an autonomously replicating shuttle vector, Proc. Natl. Acad. Sci. USA, 80, 4040, 10.1073/pnas.80.13.4040

Enger, 1986, Clonal variation of cadmium response in human-tumor cell-lines, Am. J. Phys, 250, C256

Liu, 1995, Transgenic mice that overexpress metallothionein-I are protected from cadmium lethality and hepatotoxicity, Toxicol. Appl. Pharmacol, 135, 222, 10.1006/taap.1995.1227

Masters, 1994, Targeted disruption of metallothionein-I and metallothionein-II genes increases sensitivity to cadmium, Proc. Natl. Acad. Sci. USA, 91, 584, 10.1073/pnas.91.2.584

Petrlova, 2006, Attomole voltammetric determination of metallothionein, Electrochim. Acta, 51, 5112, 10.1016/j.electacta.2006.03.078

Simpkins, 2000, Metallothionein in human disease, Cell. Mol. Biol, 46, 465

Hamer, 1988, Metallothionein—An Overview, Mar. Environ. Res, 24, 171, 10.1016/0141-1136(88)90288-7

Masters, 1994, Metallothionein-III is expressed in neurons that sequester zinc in synaptic vesicles, J. Neurosci, 14, 5844, 10.1523/JNEUROSCI.14-10-05844.1994

Moffatt, 1997, Metallothionein in physiological and physiopathological processes, Drug Metab. Rev, 29, 261, 10.3109/03602539709037585

Searle, 1984, Regulation, linkage, and sequence of mouse metallothionein-I and metallothionein-II genes, Mol. Cell. Biol, 4, 1221

Moffatt, 1998, Expression of the gene encoding metallothionein-3 in organs of the reproductive system, DNA Cell. Biol, 17, 501, 10.1089/dna.1998.17.501

Uchida, 1991, The growth inhibitory factor that is deficient in the Alzheimers-disease brain is a 68-amino acid metallothionein-like protein, Neuron, 7, 337, 10.1016/0896-6273(91)90272-2

Quaife, 1994, Induction of a new metallothionein isoform (Mt-Iv) occurs during differentiation of stratified squamous epithelia, Biochemistry, 33, 7250, 10.1021/bi00189a029

Moleirinho, 2011, Gains, losses and changes of function after gene duplication: Study of the metallothionein family, PLoS One, 6, e18487, 10.1371/journal.pone.0018487

Vallee, 1995, The function of metallothionein, Neurochem. Int, 27, 23, 10.1016/0197-0186(94)00165-Q

Wong, 2012, Zinc and its role in age-related inflammation and immune dysfunction, Mol. Nutr. Food Res, 56, 77, 10.1002/mnfr.201100511

Chasapis, 2012, Zinc and human health: An update, Arch. Toxicol, 86, 521, 10.1007/s00204-011-0775-1

Plum, 2010, The essential toxin: Impact of zinc on human health, Int. J. Environ. Res. Public Health, 7, 1342, 10.3390/ijerph7041342

Biswas, 2009, Environmental toxicity, redox signaling and lung inflammation: The role of glutathione, Mol. Aspects Med, 30, 60, 10.1016/j.mam.2008.07.001

Franklin, 2009, The important role of the apoptotic effects of zinc in the development of cancers, J. Cell. Biochem, 106, 750, 10.1002/jcb.22049

MacDonald, 2000, The role of zinc in growth and cell proliferation, J. Nutr, 130, 1500S, 10.1093/jn/130.5.1500S

Prasad, 1995, Zinc—An overview, Nutrition, 11, 93

Oteiza, 2012, Zinc and the modulation of redox homeostasis, Free Radic. Biol. Med, 53, 1748, 10.1016/j.freeradbiomed.2012.08.568

Costello, 2012, Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: An enigma and an opportunity, Expert Rev. Anticancer Ther, 12, 121, 10.1586/era.11.190

Carraway, 2012, Zinc pyrithione induces ERK- and PKC-dependent necrosis distinct from TPEN-induced apoptosis in prostate cancer cells, Biochim. Biophys. Acta, 1823, 544, 10.1016/j.bbamcr.2011.09.013

Guo, 2012, Cell apoptosis induced by zinc deficiency in osteoblastic MC3T3-E1 cells via a mitochondrial-mediated pathway, Mol. Cell. Biochem, 361, 209, 10.1007/s11010-011-1105-x

Kambe, 2004, Overview of mammalian zinc transporters, Cell. Mol. Life Sci, 61, 49, 10.1007/s00018-003-3148-y

Hogstrand, 2009, Zinc transporters and cancer: A potential role for ZIP7 as a hub for tyrosine kinase activation, Trends Mol. Med, 15, 101, 10.1016/j.molmed.2009.01.004

Hathout, 2001, Stoichiometry in zinc ion transfer from metallothionein to zinc finger peptides, Int. J. Mass Spectrom, 204, 1, 10.1016/S1387-3806(00)00343-2

Costello, 1997, Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells, J. Biol. Chem, 272, 28875, 10.1074/jbc.272.46.28875

Coffey, 2000, Thiol-Mediated apoptosis in prostate carcinoma cells, Cancer, 88, 2092, 10.1002/(SICI)1097-0142(20000501)88:9<2092::AID-CNCR15>3.0.CO;2-9

Feng, 2000, Zinc induces mitochondria apoptogenesis in prostate cells, Mol. Urol, 4, 31

Costello, 2011, Evidence for operation of the direct zinc ligand exchange mechanism for trafficking, transport, and reactivity of zinc in mammalian cells, J. Inorg. Biochem, 105, 589, 10.1016/j.jinorgbio.2011.02.002

Vallee, 1993, The biochemical basis of zinc physiology, Physiol. Rev, 73, 79, 10.1152/physrev.1993.73.1.79

Gumulec, 2011, Insight to Physiology and pathology of zinc(II) ions and their actions in breast and prostate carcinoma, Curr. Med. Chem, 18, 5041, 10.2174/092986711797636126

Aimo, 2010, Low extracellular zinc increases neuronal oxidant production through nadph oxidase and nitric oxide synthase activation, Free Radic. Biol. Med, 48, 1577, 10.1016/j.freeradbiomed.2010.02.040

Umeda, 2005, Role of reactive oxygen species in zinc deficiency-induced hepatic stellate cell activation, Free Radic. Biol. Med, 39, 631, 10.1016/j.freeradbiomed.2005.04.015

Kraus, 1997, Supplementation with vitamin C, vitamin E or beta-carotene influences osmotic fragility and oxidative damage of erythrocytes of zinc-deficient rats, J. Nutr, 127, 1290, 10.1093/jn/127.7.1290

Oteiza, 1995, Zinc-Deficiency causes oxidative damage to proteins, lipids and DNA in rat testes, J. Nutr, 125, 823

Wang, 2010, Comparative analysis of MTF-1 binding sites between human and mouse, Mamm. Genome, 21, 287, 10.1007/s00335-010-9257-7

Andrews, 2000, Regulation of metallothionein gene expression by oxidative stress and metal ions, Biochem. Pharmacol, 59, 95, 10.1016/S0006-2952(99)00301-9

Soltaninassab, 2000, Multi-faceted regulation of gamma-glutamylcysteine synthetase, J. Cell. Physiol, 182, 163, 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1

Cortese, 2008, Zinc protects endothelial cells from hydrogen peroxide via Nrf2-dependent stimulation of glutathione biosynthesis, Free Radic. Biol. Med, 44, 2002, 10.1016/j.freeradbiomed.2008.02.013

Westbrook, 1987, Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal-neurons, Nature, 328, 640, 10.1038/328640a0

Maret, 2009, Coordination dynamics of zinc in proteins, Chem. Rev, 109, 4682, 10.1021/cr800556u

Zitka, 2010, Matrix metalloproteinases, Curr. Med. Chem, 17, 3751, 10.2174/092986710793213724

Yan, 2007, Alpha-Helical linker of an artificial 6-zinc finger peptide contributes to selective DNA binding to a discontinuous recognition sequence, Biochemistry, 46, 8517, 10.1021/bi7006417

Krishna, 2003, Structural classification of zinc fingers, Nucleic Acids Res, 31, 532, 10.1093/nar/gkg161

Posewitz, 1995, Properties of the SP1 zinc-finger-3 peptide-coordination chemistry, redox reactions, and metal-binding competition with metallothionein, Chem. Res. Toxicol, 8, 1020, 10.1021/tx00050a005

Huang, 2004, Interprotein metal exchange between transcription factor IIIa and apo-metallothionein, J. Inorg. Biochem, 98, 639, 10.1016/j.jinorgbio.2004.02.004

CanoGauci, 1996, Reversible zinc exchange between metallothionein and the estrogen receptor zinc finger, FEBS Lett, 386, 1, 10.1016/0014-5793(96)00356-0

Zeng, 1991, Thionein (apometallothionein) can modulate DNA-binding and transcriptional activation by zinc finger containing factor-SP1, FEBS Lett, 279, 310, 10.1016/0014-5793(91)80175-3

Zeng, 1991, Zinc transfer from transcription factor-IIIA fingers to thionein clusters, Proc. Natl. Acad. Sci. USA, 88, 9984, 10.1073/pnas.88.22.9984

Maret, 1997, Coordination dynamics of biological zinc “clusters” in metallothioneins and in the DNA-binding domain of the transcription factor Gal4, Proc. Natl. Acad. Sci. USA, 94, 2233, 10.1073/pnas.94.6.2233

Roesijadi, 1998, Modulation of DNA binding of a tramtrack zinc finger peptide by the metallothionein-thionein conjugate pair, J. Biol. Chem, 273, 17425, 10.1074/jbc.273.28.17425

Kroncke, 2009, Zinc fingers as biologic redox switches?, Antioxid. Redox Signal, 11, 1015, 10.1089/ars.2008.2269

Maret, 1995, Metallothionein disulfide interactions, oxidative stress, and the mobilization of cellular zinc, Neurochem. Int, 27, 111, 10.1016/0197-0186(94)00173-R

Jacob, 1998, Control of zinc transfer between thionein, metallothionein, and zinc proteins, Proc. Natl. Acad. Sci. USA, 95, 3489, 10.1073/pnas.95.7.3489

Jiang, 1998, The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase, Proc. Natl. Acad. Sci. USA, 95, 3483, 10.1073/pnas.95.7.3483

Maret, 1994, Oxidative metal release from metallothionein via zinc thiol-disulfide interchange, Proc. Natl. Acad. Sci. USA, 91, 237, 10.1073/pnas.91.1.237

Kroncke, 1994, Nitric-oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9, Biochem. Biophys. Res. Commun, 200, 1105, 10.1006/bbrc.1994.1564

Wasserloos, 2002, Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein, Am. J. Physiol, 282, L185

Spahl, 2003, Regulation of zinc homeostasis by inducible NO synthase-derived NO: Nuclear translocation and intranuclear metallothionein Zn2+ release, Proc. Natl. Acad. Sci. USA, 100, 13952, 10.1073/pnas.2335190100

Malaiyandi, 2004, Divergent consequences arise from metallothionein overexpression in astrocytes: Zinc buffering and oxidant-induced zinc release, Glia, 45, 346, 10.1002/glia.10332

Pearce, 2000, Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein, Proc. Natl. Acad. Sci. USA, 97, 477, 10.1073/pnas.97.1.477

Maret, 2004, Zinc and sulfur: A critical biological partnership, Biochemistry, 43, 3301, 10.1021/bi036340p

Maret, 1998, Thiolate ligands in metallothionein confer redox activity on zinc clusters, Proc. Natl. Acad. Sci. USA, 95, 3478, 10.1073/pnas.95.7.3478

Maret, 2011, Redox biochemistry of mammalian metallothioneins, J. Biol. Inorg. Chem, 16, 1079, 10.1007/s00775-011-0800-0

Cherian, 2003, Metallothioneins in human tumors and potential roles in carcinogenesis, Mutat. Res, 533, 201, 10.1016/j.mrfmmm.2003.07.013

Ebadi, 1996, The antioxidant properties of zinc and metallothionein, Neurochem. Int, 29, 159, 10.1016/0197-0186(95)00116-6

Kang, 2006, Metallothionein redox cycle and function, Exp. Biol. Med, 231, 1459, 10.1177/153537020623100903

Sato, 1993, Oxygen free-radicals and metallothionein, Free Radic. Biol. Med, 14, 325, 10.1016/0891-5849(93)90029-T

Iszard, 1995, Effect of several metallothionein inducers on oxidative stress defense mechanisms in rats, Toxicology, 104, 25, 10.1016/0300-483X(95)03118-Y

Aschner, 1998, Induction of astrocyte metallothioneins (MTs) by zinc confers resistance against the acute cytotoxic effects of methylmercury on cell swelling, Na+ uptake, and K+ release, Brain Res, 813, 254, 10.1016/S0006-8993(98)00947-0

Namdarghanbari, 2011, Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy, J. Biol. Inorg. Chem, 16, 1087, 10.1007/s00775-011-0823-6

Cai, 1995, Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro, Chem. Biol. Interact, 96, 143, 10.1016/0009-2797(94)03585-V

Shibuya, 2008, Role of metallothionein as a protective factor against radiation carcinogenesis, J. Toxicol. Sci, 33, 651, 10.2131/jts.33.651

Schwarz, 1995, Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric-oxide, Proc. Natl. Acad. Sci. USA, 92, 4452, 10.1073/pnas.92.10.4452

Kondo, 1997, Enhanced apoptosis in metallothionein null cells, Mol. Pharmacol, 52, 195, 10.1124/mol.52.2.195

Tao, 2007, Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma, Hepatol. Res, 37, 820, 10.1111/j.1872-034X.2007.00113.x

Fraker, 2001, A distinct role for apoptosis in the changes in lymphopoiesis and myelopoiesis created by deficiencies in zinc, FASEB J, 15, 2572, 10.1096/fj.01-0430rev

Mao, 2012, Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas, Carcinogenesis, 33, 2568, 10.1093/carcin/bgs287

Yan, 2012, Downregulation of Metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue, Biochim. Biophys. Acta, 1822, 918, 10.1016/j.bbadis.2012.02.021

Faller, 2010, Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis, Melanoma Res, 20, 392, 10.1097/CMR.0b013e32833d32a6

Takahashi, 2012, Molecular functions of metallothionein and its role in hematological malignancies, J. Hematol. Oncol, 5, 1, 10.1186/1756-8722-5-41

Sikora, 2008, The possible biological role of metallothionein in apoptosis, Front. Biosci, 13, 4029

McGee, 2010, The two faces of metallothionein in carcinogenesis: Photoprotection against UVR-induced cancer and promotion of tumour survival, Photochem. Photobiol. Sci, 9, 586, 10.1039/b9pp00155g

Chaabane, 2013, Autophagy, apoptosis, mitoptosis and necrosis: Interdependence between those pathways and effects on cancer, Arch. Immunol. Ther. Exp, 61, 43, 10.1007/s00005-012-0205-y

Ouyang, 2012, Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis, Cell. Prolif, 45, 487, 10.1111/j.1365-2184.2012.00845.x

Nath, 2000, Metallothioneins, oxidative stress and the cardiovascular system, Toxicology, 155, 17, 10.1016/S0300-483X(00)00273-0

Wyllie, 1997, Apoptosis: An overview, Br. Med. Bull, 53, 451, 10.1093/oxfordjournals.bmb.a011623

Thornberry, 1998, Caspases: Enemies within, Science, 281, 1312, 10.1126/science.281.5381.1312

Wyllie, 1999, Apoptosis and carcinogenesis, Br. J. Cancer, 80, 34

Dhawan, 2010, Zinc: A promising agent in dietary chemoprevention of cancer, Indian J. Med. Res, 132, 676

Telford, 1995, Preferential induction of apoptosis in mouse CD4(+)CD8(+)alphabeta- tcr(lo)CD3-epsilon(lo) thymocytes by zinc, J. Cell. Physiol, 164, 259, 10.1002/jcp.1041640206

Perry, 1997, Zinc is a potent inhibitor of the apoptotic protease, caspase-3—A novel target for zinc in the inhibition of apoptosis, J. Biol. Chem, 272, 18530, 10.1074/jbc.272.30.18530

Stefanidou, 2006, Zinc: A multipurpose trace element, Arch. Toxicol, 80, 1, 10.1007/s00204-005-0009-5

Seve, 2002, Role of intracellular zinc in programmed cell death, Pathol. Biol, 50, 212, 10.1016/S0369-8114(02)00290-0

Fan, 2002, Potential role of p53 on metallothionein induction in human epithelial breast cancer cells, Br. J. Cancer, 87, 1019, 10.1038/sj.bjc.6600549

Meplan, 1999, Metal ions as regulators of the conformation and function of the tumour suppressor protein p53: Implications for carcinogenesis, Proc. Nutr. Soc, 58, 565, 10.1017/S0029665199000749

Meplan, 2000, Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells, Oncogene, 19, 5227, 10.1038/sj.onc.1203907

Maret, 1999, Inhibitory sites in enzymes: Zinc removal and reactivation by thionein, Proc. Natl. Acad. Sci. USA, 96, 1936, 10.1073/pnas.96.5.1936

Woo, 1996, Nucleophilic distribution of metallothionein in human tumor cells, Exp. Cell. Res, 224, 365, 10.1006/excr.1996.0146

Milnerowicz, 2009, Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas, Arch. Immunol. Ther. Exp, 57, 295, 10.1007/s00005-009-0033-x

Cardoso, 2009, Expression of metallothionein and p53 antigens are correlated in oral squamous cell carcinoma, Anticancer Res, 29, 1189

Baldwin, 2001, Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappa B, J. Clin. Invest, 107, 241, 10.1172/JCI11991

Karin, 2002, NF-Kappa B in cancer: From innocent bystander to major culprit, Nat. Rev. Cancer, 2, 301, 10.1038/nrc780

Wang, 1998, NF-kappa B antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation, Science, 281, 1680, 10.1126/science.281.5383.1680

Wang, 1999, NF-kappa B induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis, Mol. Cell. Biol, 19, 5923, 10.1128/MCB.19.9.5923

Wu, 1998, IEX-1L, an apoptosis inhibitor involved in NF-kappa B-mediated cell survival, Science, 281, 998, 10.1126/science.281.5379.998

Butcher, 2004, Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts, J. Pharmacol. Exp. Therapeutics, 310, 589, 10.1124/jpet.104.066126

Kim, 2003, Zinc-Induced NF-kappa B inhibition can be modulated by changes in the intracellular metallothionein level, Toxicol. Appl. Pharmacol, 190, 189, 10.1016/S0041-008X(03)00167-4

Agrawal, 1998, Activation of nuclear factor kappa B: Potential role in metallothionein-mediated mitogenic response, Cancer Res, 58, 2335

Wang, 1999, Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappa B, Nat. Med, 5, 412, 10.1038/7410

Kanekiyo, 2001, Zinc-induced activation of the human cytomegalovirus major immediate-early promoter is mediated by metallothionein and nuclear factor-kappa B, Toxicol. Appl. Pharmacol, 173, 146, 10.1006/taap.2001.9173

Thornalley, 1985, Possible role for metallothionein in protection against radiation-induced oxidative stress—Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals, Biochim. Biophys. Acta, 827, 36, 10.1016/0167-4838(85)90098-6

Abel, 1989, Inhibition of hydroxyl-radical-generated DNA-degradation by metallothionein, Toxicol. Lett, 47, 191, 10.1016/0378-4274(89)90075-1

Cai, 2000, Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage, J. Biol. Chem, 275, 38957, 10.1074/jbc.C000593200

Schwarz, 1994, Cytoplasmic metallothionein overexpression protects NIH 3T3 cells from tert-butyl hydroperoxide toxicity, J. Biol. Chem, 269, 15238, 10.1016/S0021-9258(17)36597-3

Du, 1994, Mechanism of gentamicin-nephrotoxicity in rats and the protective effect of zinc-induced metallothionein synthesis, Nephrol. Dial. Transplant, 9, 135

Yang, 1994, Zinc-Induced metallothionein synthesis could protect from gentamicin-nephrotoxicity in suspended proximal tubules of rats, Renal Fail, 16, 61, 10.3109/08860229409044848

Hart, 1995, Increased oxidant resistance of alveolar epithelial type II cells. Isolated from rats following repeated exposure to cadmium aerosols, Toxicol. Lett, 81, 131, 10.1016/0378-4274(95)03417-X

Satoh, 1993, Prevention of carcinogenicity of anticancer drugs by metallothionein induction, Cancer Res, 53, 4767

Satoh, 1992, Effect of preinduction of metallothionein on paraquat toxicity in mice, Arch. Toxicol, 66, 145, 10.1007/BF02342510

Quesada, 1996, Direct reaction of H2O2 with sulfhydryl groups in HL-60 cells: Zinc-metallothionein and other sites, Arch. Biochem. Biophys, 334, 241, 10.1006/abbi.1996.0452

Chubatsu, 1993, Metallothionein protects DNA from oxidative damage, Biochem. J, 291, 193, 10.1042/bj2910193

Banerjee, 1982, Immunohistochemical localization of metallothionein in cell-nucleus and cytoplasm of rat-liver and kidney, Toxicology, 24, 95, 10.1016/0300-483X(82)90048-8

Nagel, 1995, Cell-Cycle regulation of metallothionein in human colonic-cancer cells, Proc. Natl. Acad. Sci. USA, 92, 579, 10.1073/pnas.92.2.579

Ghoshal, 2001, Regulation of metallothionein gene expression, Prog. Nucl. Res. Mol. Biol, 66, 357, 10.1016/S0079-6603(00)66034-8

Tsujikawa, 1991, Localization of metallothionein in nuclei of growing primary cultured adult-rat hepatocytes, FEBS Lett, 283, 239, 10.1016/0014-5793(91)80597-V

Takahashi, 2004, Role of metallothionein in the cell cycle: Protection against the retardation of cell proliferation by endogenous reactive oxygen species, J. Health Sci, 50, 154, 10.1248/jhs.50.154

Takahashi, 2004, Synchronized generation of reactive oxygen species with the cell cycle, Life Sci, 75, 301, 10.1016/j.lfs.2003.12.014

Takahashi, 2005, Nuclear trafficking of metallothionein requires oxidation of a cytosolic partner, J. Cell. Physiol, 202, 563, 10.1002/jcp.20158

Ogra, 2008, Enhancement of nuclear localization of metallothionein by nitric oxide, J. Health Sci, 54, 339, 10.1248/jhs.54.339

Eckschlager, 2009, Metallothioneins and cancer, Curr. Protein Peptide Sci, 10, 360, 10.2174/138920309788922243

Sato, 1991, Dose-Dependent increases in metallothionein synthesis in the lung and liver of paraquat-treated rats, Toxicol. Appl. Pharmacol, 107, 98, 10.1016/0041-008X(91)90334-B

Sato, 1995, Antioxidative roles of metallothionein and manganese superoxide-dismutase induced by tumor-necrosis-factor-alpha and interleukin-6, Arch. Biochem. Biophys, 316, 738, 10.1006/abbi.1995.1098

Shiraishi, 1986, Increased metallothionein content in rat-liver and kidney following X-irradiation, Toxicol. Appl. Pharmacol, 85, 128, 10.1016/0041-008X(86)90106-7

Koropatnick, 1989, Organ-specific metallothionein induction in mice by X-irradiation, Radiat. Res, 119, 356, 10.2307/3577626

Shibuya, 1995, Induction of metallothionein synthesis in transplanted murine tumors by X-irradiation, Radiat. Res, 143, 54, 10.2307/3578925

Matsubara, 1987, Promotion of radioresistance by metallothionein induction prior to irradiation, Environ. Res, 43, 66, 10.1016/S0013-9351(87)80058-0

Matsubara, 1988, Metallothionein induction—A measure of radioprotective action, Health Phys, 55, 433, 10.1097/00004032-198808000-00043

Liu, 1999, Metallothionein-I transgenic mice are not protected from gamma-radiation, Toxicol. Lett, 104, 183, 10.1016/S0378-4274(98)00362-2

Sun, 2001, Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart, Cancer Res, 61, 3382

Kang, 2003, Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transigenic mice, Am. J. Pathol, 163, 1579, 10.1016/S0002-9440(10)63514-6

Cai, 2005, Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy, Diabetes, 54, 1829, 10.2337/diabetes.54.6.1829

Wang, 2005, Alcohol-Induced myocardial fibrosis in metallothionein-null mice—Prevention by zinc supplementation, Am. J. Pathol, 167, 337, 10.1016/S0002-9440(10)62979-3

Merten, 2005, Modulation of cytochrome c oxidase-Va is possibly involved in metallothionein protection from doxorubicin cardiotoxicity, J. Pharmacol. Exp. Ther, 315, 1314, 10.1124/jpet.105.089763

Zhou, 2008, Metallothionein suppresses angiotensin II-Induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart, J. Am. Coll. Cardiol, 52, 655, 10.1016/j.jacc.2008.05.019

Egli, 2006, A family knockout of all four Drosophila metallothioneins reveals a central role in copper homeostasis and detoxification, Mol. Cell. Biol, 26, 2286, 10.1128/MCB.26.6.2286-2296.2006

Krizkova, 2012, Metallothioneins and zinc in cancer diagnosis and therapy, Drug Metab. Rev, 44, 287, 10.3109/03602532.2012.725414